Lesokhin, AM
283  Ergebnisse:
Personensuche X
?
2

EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSE..:

Nooka, A ; Lesokhin, A ; Mohty, M...
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S405 , 2023
 
?
3

ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANT..:

Mohty, M ; Tomasson, M ; Arnulf, B...
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S404-S405 , 2023
 
?
4

EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PA..:

Raje, N ; Leleu, X ; Lesokhin, A...
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S406-S407 , 2023
 
?
8

A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN..:

Lesokhin, AM ; Arnulf, B ; Niesvizky, R...
Hematology, Transfusion and Cell Therapy.  44 (2022)  - p. S245-S246 , 2022
 
?
10

EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL ..:

Solh, M ; Bahlis, NJ ; Raje, NS...
Hematology, Transfusion and Cell Therapy.  43 (2021)  - p. S195-S196 , 2021
 
?
11

Upfront plerixafor plus G-CSF versus cyclophosphamide plus ..:

Afifi, S ; Adel, N G ; Devlin, S...
Bone Marrow Transplantation.  51 (2016)  4 - p. 546-552 , 2016
 
?
12

CD34-selected allogeneic hematopoietic stem cell transplant..:

Koehne, G. ; Devlin, S. ; Landau, H....
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  - p. e280 , 2015
 
?
13

A Pilot Study of T-Cell Depleted Allogeneic Hematopoietic S..:

Koehne, G. ; Landau, H. ; Hassoun, H....
Biology of Blood and Marrow Transplantation.  17 (2011)  2 - p. S286 , 2011
 
?
 
1-15